Private Investment Opportunity

Phase One: Digital Platform Completion

Bio Longevity is completing a dedicated development sprint to launch our consumer-ready mobile training platform. We are raising a defined tranche to deliver a specific outcome.

View Full Scope Request Information
Raise Amount
$90,000 AUD
Development Period
6 Months
Deliverable
Live App V1
Structure
Convertible Note

What This Raise Is For

Bio Longevity is building a digital-first mobile training platform in the wellness and longevity space. This raise funds the completion of our Phase One product: a consumer-ready, subscription-based mobile application.

This is not an ongoing capital raise. This is not a request to fund physical centres or equipment. This is a time-boxed development tranche with a defined scope, a clear timeline, and a specific outcome.

At the end of Phase One, Bio Longevity will have a live, revenue-generating product. The company will then be in a position to raise subsequent rounds on stronger terms, or to fund operations from revenue.

Phase One Scope

The following features and systems will be delivered as part of this development sprint.

Core App Experience
  • Mobile-first guided workout engine with card-based session flow
  • Integrated timers, rep counters, and rest period management
  • User accounts with secure authentication and cloud sync
  • Exercise library with goal and body area selection
Training Programs
  • Standard structured strength training programs
  • Circuit and F45-style high-intensity interval programs
  • Mobility and Tai Chi recovery sessions
  • Program scheduling and session management
Nutrition Module
  • Curated meal ideas aligned with training goals
  • Protein shake and supplement guidance
  • Simple dietary guidance and macro targets
Progress Tracking
  • Completed session history and workout logs
  • Consistency streaks and achievement tracking
  • Weight entries and basic body metrics
Subscription System
  • Integrated payment processing (Stripe / Apple Pay / Google Pay)
  • Tiered subscription plans with access control
  • Trial periods and promotional code support
Backend & Analytics
  • Admin dashboard for content management
  • User engagement and retention analytics
  • Revenue reporting and subscription metrics
Explicitly Not Included in Phase One

The following are part of Bio Longevity's long-term vision but are not included in this raise:

  • Physical centre rollout or fit-outs
  • Equipment purchasing or leasing
  • Custom wearables (smartwatch/scales)
  • Advanced medical or clinical integrations

Development Timeline

A six-month sprint with defined milestones and deliverables.

Month 1: Foundations

Core workout engine architecture, user authentication system, backend infrastructure, and base UI components.

1
Month 2: Core Experience

Exercise library population, goal selection flow, workout routing logic, and initial QA testing.

2
Month 3: Program Expansion

Circuit training mode, mobility/Tai Chi sessions, program scheduling, and session management features.

3
Month 4: Nutrition & Tracking

Meal planning module, shake/supplement guidance, progress tracking dashboard, and weight entry system.

4
Month 5: Subscriptions & Testing

Payment integration, subscription tiers, beta testing program, bug fixes, and performance optimisation.

5
Month 6: Launch

User onboarding flow, final polish, App Store / Play Store submission, analytics setup, and public launch.

Funding Structure

A clean, time-boxed instrument designed for early-stage development funding.

Raise Amount
$90,000 AUD
Instrument Type
Convertible Note
Use of Funds
Phase One development sprint (6 months)
Conversion Trigger
Future priced equity round
Conversion Terms
Discount to future round valuation

Specific discount rate provided under NDA

Minimum Investment
Available on request

What Comes After Phase One

Phase One delivers a live, revenue-generating product. Once the app is launched and generating subscription revenue, Bio Longevity's funding position changes fundamentally.

Phase Two: Product Expansion

Additional training modalities (Pilates, yoga, martial arts), advanced nutrition features, wearable device integration, and expanded content library. This phase may be funded from revenue or through a subsequent raise.

Phase Three: Physical Centres

Rollout of physical Bio Longevity centres with equipment, fit-outs, and location-based services. This is a capital-heavy phase that uses different investor structures and is not part of this raise.

Phase Four: Infrastructure

Equipment ownership, leasing arrangements, and infrastructure finance. This is a later-stage, asset-backed investment opportunity that follows successful centre operations.

Investor FAQ

Common questions about this investment opportunity.

The product is in active development. This raise funds the completion of the Phase One development sprint, which will result in a live, consumer-ready mobile application. The existing Bio Longevity web platform demonstrates our technical capabilities and design direction.

Funds will be used for a dedicated six-month development sprint to complete the Phase One product scope. This includes development costs, design work, testing, cloud infrastructure, and App Store / Play Store fees. A detailed budget breakdown is available to qualified investors under NDA.

Raising now allows Bio Longevity to complete a defined product and reach revenue faster than bootstrapping alone. This creates a stronger foundation for future raises, better terms for the company, and a clearer value proposition for subsequent investors. Early investors benefit from conversion discounts that reward this stage of risk.

Investors in this round receive a convertible note that converts to equity at a discount in a future priced round. This means early investors receive more equity for their capital than later investors paying the full valuation. The specific discount rate and terms are provided under NDA. We do not make projections about returns, as early-stage investments carry inherent risk.

No. The convertible note has a defined term. If a priced round occurs within the term, the note converts to equity at the agreed discount. If no priced round occurs, alternative exit provisions apply as specified in the investment documentation. This is not a perpetual or open-ended investment structure.

No. This raise is exclusively for the digital platform. Physical centre rollout, equipment purchasing, and fit-outs are part of Bio Longevity's long-term vision but are funded through separate, later-stage investment structures. Investors in this round are investing in the digital product only.

Interested investors can request the full investment documentation, including detailed budget, conversion terms, and legal agreements, by contacting us using the form below. We will arrange a call to discuss the opportunity and answer any questions before providing documentation under NDA.

Request Investment Information

If you are interested in participating in this raise, please get in touch. We will arrange a call to discuss the opportunity and provide full documentation under NDA.

invest@biolongevitycentres.com.au Schedule a Call

This page is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. Any investment involves risk.

This page is intended for potential investors only. For consumer information about Bio Longevity services, please visit biolongevity.com.au.